Abstract: Under aerobic, high glucose conditions, Saccharomyces cerevisiae exhibits glucose repression and thus a predominantly fermentative metabolism. Here, we show that two commonly used prototrophic representatives of the CEN.PK and S288C strain families respond differently to deletion of the hexokinase 2 (HXK2) -a key player in glucose repression: In CEN.PK, growth rate collapses and derepression occurs on the physiological level, while the S288C descendant FY4 Dhxk2 still grows like the parent strain and shows a fully repressed metabolism. A CEN.PK Dhxk2 strain with a repaired adenylate cyclase gene CYR1 maintains repression but not growth rate. A comparison of the parent strain's physiology, metabolome, and proteome revealed higher metabolic rates, identical biomass, and byproduct yields, suggesting a lower Snf1 activity and a higher protein kinase A (PKA) activity in CEN.PK. This study highlights the importance of the genetic background in the processes of glucose signaling and regulation, contributes novel evidence on the overlap between the classical glucose repression pathway and the cAMP/PKA signaling pathway, and might have the potential to resolve some of the conflicting findings existing in the field. 
Introduction
Under high glucose conditions and despite the presence of oxygen, the yeast Saccharomyces cerevisiae shows an almost exclusively fermentative metabolism, which is characterized by excretion of ethanol and absence of respiratory activity (Carlson, 1999 , Rolland, et al., 2002 . This effect is called catabolite or glucose repression and is reminiscent of the Warburg effect that occurs in several tumor cells (Johnston & Kim, 2005) . Next to the distinct physiology, invertase (SUC2) expression/activity is also frequently used in the community as a reporter for the state of glucose repression.
Glucose repression in yeast is primarily realized by the Hxk2/Snf1 pathway (Gancedo, 1998 , Rolland, et al., 2002 . While quite some molecular details of this pathway have been elucidated, a holistic understanding of its complete functioning still remains elusive (Bisson & Kunathigan, 2003) . It is clear, however, that the glucose phosphorylating enzyme hexokinase 2 (Hxk2) has a pivotal regulatory role (Randez-Gil, et al., 1998 , de la Cera, et al., 2002 , Ahuatzi, et al., 2004 , Ahuatzi, et al., 2007 . There is certain indication that the glycolytic flux might be the signal that determines the degree of glucose repression (Jiang, et al., 2000 , Elbing, et al., 2004 , Otterstedt, et al., 2004 . A classical experiment in the field of glucose repression is the deletion of the Hxk2. Using auxotrophic strains, it was originally found that glucose repression is relieved as identified on the basis of increased SUC2 expression/activity (Zimmermann & Scheel, 1977 , Entian, 1980 , Ma & Botstein, 1986 . Subsequent work, however, has shown that when Hxk2 is not present, hexokinase 1 (Hxk1) can also maintain glucose repression (Rose, et al., 1991 , De Winde, et al., 1996 . Such conflicting findings with respect to the effect of HXK2 deletions on glucose repression can likely be explained by the fact that the used strains were not genetically identical. In some strains, the redundancy in the form of the Hxk1 isoenzyme might compensate for the loss of Hxk2. Alternatively, the cAMP/protein kinase A (PKA) pathway, which also has a role in regulating Snf1 (Hedbacker, et al., 2004 , Slattery, et al., 2008 , could realize Hxk1/2-independent degree of glucose repression (Mbonyi, et al., 1990 , Zaragoza, et al., 1999 . Overall, conflicting findings such as those on the effect of HXK2 deletions with respect to glucose repression and the application of different means to assess glucose repression (i.e. SUC2 expression/activity vs. physiological quantification of glucose repression) certainly hamper further progression of the field.
Focusing on the eventual physiological manifestation of glucose repression, we comparatively investigated prototrophic representatives of two important yeast strain families that are frequently used to study glucose signaling and regulation and that show different responses to HXK2 deletions: The CEN.PK strain, a prominent yeast reference strain selected in a multi-lab effort (van Dijken, et al., 2000) shows on the physiological level a completely derepressed metabolism upon deletion of the HXK2 gene.
In contrast, the FY4 strain (Winston, et al., 1995) -a descendent of the first sequenced yeast strain and a prototrophic version of the strain BY strain with which most strain libraries were generatedphysiologically fully retains the state of glucose repression when the same gene is deleted. A recent genome-wide analysis of nucleotide-level variations in S. cerevisiae strains has revealed that the FY4 strain -which is nearly identical to the BY4716 strain investigated in this analysis (Brachmann, et al., 1998) -and the CEN.PK strain are rather similar: genetic variation was found in only a small fraction of the genome (80% of the single nucleotide polymorphisms in CEN.PK in 18% of the genome) and only 17 genes in CEN.PK carry a whole or a partial (longer than 500 bps in size) deletion in comparison to BY4716 (with 41% of those genes not having assigned a biological function) (Schacherer, et al., 2007) .
In this paper we set out to investigate the differences in these two strains under high glucose conditions. Specifically, we aimed at elucidating why these two strains respond differently on physiological level upon a deletion of the HXK2 gene and whether the known defect in the CYR1 gene (encoding adenylate cyclase; involved in cAMP synthesis) in CEN.PK (Vanhalewyn, et al., 1999) is responsible for the different behavior. We compare the physiology, metabolome, and proteome of the two yeast strains and a variant of one of them. We find significant differences between these strains providing compelling evidence for the effect of the genetic background on major metabolic pathways like those involved in glucose signaling in yeast. Furthermore, our study provides support for an earlier hypothesized link between the classical glucose repression pathway and the glucose activated cAMP/PKA signaling pathway.
Materials and Methods

Strains and culture conditions
The strains used in this study are listed in Tab. 1. In CEN.PK JT4, the HXK2 gene was deleted by the short flanking homology method using the loxP-kanMX4-loxP gene disruption cassette (Guldener, et al., 1996) .
The deletion cassette was amplified from pUG6, using as a forward primer 5'-TCTTTGTTGCACCTTCGCCACTGTCTTATCTACAAAACTACTTCGTACGCTGCAGGTC-3', which includes 18 nucleotides complementary to pUG6 and a 40-nucleotide extension corresponding to the region -150 to -110 upstream of the start codon of the HXK2 ORF, and as a reverse primer 5'-AGTACGCAAGCTATCTAGAGGAAGTGTAGAGAGGGTTAAATAGTGGATCTGATATCACCTA-3', which includes 21 nucleotides complementary to pUG6 and 40 nucleotides corresponding to the region +1851 to +1811 downstream of the start codon of the HXK2 ORF. Deletion of the HXK2 ORF was confirmed by PCR on genomic DNA extracted from G418R transformants.
In all experiments, cells were grown in minimal defined medium with glucose as sole carbon source. The medium was prepared from autoclaved salt and glucose solutions and sterile filtered solutions of vitamins and trace metals to reach concentrations as described in (Verduyn, et al., 1992) . Liquid precultures with 10 g/l glucose were inoculated by colonies from YPD plates. In all experiments, the glucose concentration was 10 g/l and the temperature was maintained at 30°C. Phtalate buffer (10 mM for shake flask experiments, 90 mM for 13 C labeling experiments) was used to maintain pH at a value of 5.
Sequencing of HXK2 gene
The HXK2 gene was amplified by PCR from the FY4 and CEN.PK genome using a primers pair (5' CTTTGAAAAGGTTGTAGGAA 3' and 5' TAGAAAAAGGGCACCTTCTT 3') to amplify a region of 1571 bp containing the gene. The resulting PCR product was cleaned with the QIAquick PCR Purification kit (Qiagen, Valencia, CA, USA), and was send to Microsynth AG (Balgach, Switzerland) for sequencing with the PCR primers and two internal primers (5' ATATCGGAACAAACATCGTA 3' and 5' TACACTGACCCAGAAACTAA 3'). The resulting four sequenced fragments were aligned and compared with the YGL253W gene from the Saccharomyces Genome Database (Tettelin, et al., 1997) .
Biomass and extracellular metabolite concentrations
Biomass concentrations were monitored by measuring optical density (OD) at 600 nm with a spectrophotometer (Pharmacia Novaspec II). The biomass dry weight was calculated using an earlier determined OD-to-biomass dry weight (DW) correlation coefficient of 0.486 OD l gDW / for FY4 and 0.52 OD l gDW / for CEN.PK strains. To determine the extracellular concentrations of glucose, ethanol, acetate, pyruvate, and glycerol, 1 ml samples were taken and centrifuged for 4 min at 4000 rpm at 4°C. Unless otherwise noted, the supernatant was analyzed with an HPLC system (Agilent HP1100), equipped with a polymer column (Aminex HPX-87, BioRad). As eluent 5 mM H2SO4 was used and the column was heated to 60°C. The compounds were detected and quantified with a refractive index (RI) detector and an UV/Vis-detector (DAD). For absolute quantification, calibration curves with external standards for the corresponding pure substance obtained from Sigma were used. Growth rates, µ, and biomass yields, glc x Y , were calculated by linear regression (Matlab, function regress.m) using the following equations,
respectively, based on the biomass concentrations, x, and extracellular glucose concentrations, cglc obtained from all biological replicates. The yields of ethanol, acetate, glycerol, and pyruvate were calculated by using equations analog to Eqn. 2. The remaining uptake and production rates were determined from the estimated values.
Respiratory TCA cycle activity
The respiratory TCA cycle activity was determined from 13 C-labeling experiments, where 20% of the glucose in the medium was uniformly labeled (≥ 99% enrichment, obtained from Cambridge Isotope Labs). These experiments were carried out in deep well plates with a culture volume of 1.2 ml and the biomass concentration was measured at 600 nm (Spectra MAX Plus, Bucher Biotec AG). Cultures were harvested during exponential growth at ODs between 0.8 and 1.3 and centrifuged at 4°C and 4000 rpm for 3 min. Supernatant and cell pellets were separately frozen at -40°C. Extracellular metabolite concentrations in the supernatant were determined via HPLC-RI/DAD methods as described above.
To determine the labeling patterns in proteogenic amino acids, samples were prepared and analyzed by GC-MS. Cell pellets were hydrolyzed in 180 µl 6 M HCl at 105 °C for 12 h and the hydrolysate dried at 95°C. The free amino acids were derivatized at 85 °C for 1 h using 20 µl dimethylformamide and 20 µl N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide +1% tert-butyldimethylchlorosilane. GC-MS analysis was carried out using a GC (series 6890N, Agilent Technologies) in combination with a mass spectrometer (5973, Agilent Technologies) (Fischer, et al., 2004) . The respiratory TCA cycle activity was calculated from the fraction of mitochondrial oxaloacetate from anaplerosis, which was calculated from 13 C-labeling patterns using FiatFlux (Zamboni, et al., 2005) .
Intracellular metabolite concentrations
Intracellular metabolite concentrations of two biological and two technical replicates were determined from samples withdrawn from culture at an OD of approximately 1.5. To quench metabolism and extract intracellular metabolites, the following procedure was applied (adapted from (de Koning & van Dam, 1992 , Gonzalez, et al., 1997 ). Samples of 1-4 ml were taken at each sampling time point and quenched in methanol at -40°C. For the determination of the cAMP concentrations a sample volume of 10 ml was taken. After centrifuging for 3 min at 14000 rpm in a rotor pre-cooled to -9°C, they were frozen at -40°C.
Intracellular metabolites were extracted by incubation in 75% ethanol for 3 min at 95°C. The supernatant was collected after centrifuging in a pre-cooled rotor (-9°C).
For quantification by GC-TOF, two sample aliquots were derivatized with either TMS-agent (N-Methyl-N-
The samples were separated via GC on a HP5-MS column (HewlettPackard, length 30m x ID 0.25 x film 0.25 µm) and injected for MS analysis to a TOF spectrometer (Pegasus III, Leco). Detailed information on process parameters are described in (Ewald, et al., 2009 ).
Leco ChromaTOF software (version 2.32) was used for acquisition. An autosampler (MPS2, Gerstel)
controlled by Gerstel Maestro software was used to derivatize samples just-in-time prior to injection to the GC-TOF system.
For quantification by LC-MS/MS, an ion-pairing reverse phase LC method was adapted from (Luo, et al., 2007) . The mobile phase was composed of eluent A (aqueous solution of 10 mM tributylamine and 15 mM acetic acid) and eluent B (methanol); the gradient profile was as follows: t = 0 min, 0% B; t = 15 min, 55% B; t = 27 min, 66% B; t = 28 min, 100% B. The end-capped C18 column (Synergi Hydro RP, 2.1 x 150 mm, 4 µm particles; Phenomenex) was employed.
The column was equilibrated for 20 min before each injection, the flow rate was 200 µL/min, the column temperature was controlled at 40°C; the injection volume was 8 µL. For tandem MS analysis, an Applied Biosystems/MDS Sciex 4000 QTRAP mass spectrometer (AB/MDS Sciex) was coupled to the LC. The
Analyst software (version 1.4.2, AB/MDS Sciex) was used for acquisition and peak integration. All analyses were performed in negative mode and selected reaction-monitoring mode with Q1 and Q3 set to unit resolution. Ion spray voltage, auxiliary gas temperature, nebulizer gas, auxiliary gas, curtain gas and collision gas were set to -4200 V, 650°C, 65, 40, 10, 4 (arbitrary units), respectively. Nitrogen (Pangas) was used as curtain and collision gas.
Declustering potential, collision energy and collision cell exit potential were optimized separately for each compound. To obtain temporal resolution of 1 Hz or greater for each transition, the run was divided into five segments and the dwell time for each transition was set to 50 ms.
To calculate intracellular concentrations, we used a conversion factor of 2 µl/mgCDW. Standard errors 
Protein abundances
To determine protein concentration, duplicate samples of 25 ml were harvested on ice and washed twice with 5 ml washing buffer (20 mM HEPES pH 7.5, 2 mM EDTA). During washing, the protein samples were centrifuged for 5 min at 5000 rpm at 4°C and the supernatant discarded afterwards. Cell pellets were frozen at -80°C.
For protein extraction, the cell pellets were thawed and resuspended in an ice cold lysis buffer containing 20 mM TrisHCl pH 8.0, 2 mM DTT, 100 mM KCl, 10 mM EDTA, and complete yeast protease inhibitors cocktail (Roche), using 1 ml of lysis buffer per gram of yeast. acetonitrile. Peptides were evaporated on a vacuum centrifuge to dryness, resolubilized in 0.1% formic acid and immediately analyzed.
Protein abundances were determined by a selective/multiple reaction monitoring (S/MRM) based mass spectrometry approach as follows. For each target protein, a set of five proteotypic peptides preferentially observed in shotgun proteomics experiments (King, et al., 2006) or predicted to have suitable MS properties (Mallick, et al., 2007) was selected for S/MRM analysis. For each peptide, 3-8 transitions were calculated, corresponding to fragment ions of the y-series. Fragment ions with m/z above the precursor ion m/z were prioritized. The precursor/fragment ion transitions were used to detect by S/MRM the peptides of interest in whole S. cerevisiae protein digests and to trigger acquisition of the full fragment ion spectra of the peptides (S/MRM-triggered MS2), as previously described (Picotti, et al., 2008) . Each SRM assay was validated by acquiring a full tandem mass spectrum of the corresponding peptide.
Samples were analyzed on a hybrid triple quadrupole/ion trap mass spectrometer ( coordinates for the S/MRM assays is described elsewhere (Picotti, et al., 2008) . 
Osmotic shock experiments
To determine the survival rate after hyperosmotic shock, we adapted a method reported in (Beney, et al., 2001) . Colony forming units (CFU) for an aliquot of yeast culture exposed to hyperosmotic shock and a non-treated aliquot -both from an exponentially growing culture -were counted. For hyperosmotic shock treatment, an aliquot of 1 ml was mixed with 9 ml autoclaved glycerol/water solution (116.9 g glycerol in 50 ml water, approx. 65 mPa) and left for 40 min at room temperature. Both treated and nontreated samples were diluted 33000 and 66000 times respectively in autoclaved isotonic NaCl solution (9 g/l) and 200 µl spread on YPD plates. After two days of incubation at 30°C, photographs were taken and the CFU counted. The survival rate was calculated as the ratio of CFU of treated versus non-treated samples.
Transcription factor analysis of protein abundances
Transcription factors, which are more often than by chance associated with the subset of proteins that are 3-times lower abundant in CEN.PK compared to FY4 were determined by a statistical enrichment analysis adopted from (Boyle, et al., 2004) . We here applied the documented transcription factor-gene associations reported by (Teixeira, et al., 2006) . For each transcription factor (TF) that has at least one interaction with any of the measured proteins a p-value based on a hypergeometric distribution was calculated:
Here, N is the total number of proteins measured and n the number of proteins that are 3-times lower abundant in CEN.PK. Mj and kj are the number of measured proteins and the number of measured, 3-times lower abundant proteins in CEN.PK respectively, that interact with TF j. The such calculated pvalue gives the probability that the TF has at least the observed number of interactions with the subset of lower abundant proteins. Detailed results are provided in Supplementary Table 1.
Results
Between the two here compared strains, there is one known genetic difference that likely is relevant for glucose signaling and regulation: a point mutation in the CEN.PK's CYR1 gene encoding the adenylate cyclase prevents this strain to show the otherwise typical cAMP increase upon sudden glucose excess (Vanhalewyn, et al., 1999) , thus in principle lacking the PKA pathway as an alternative mean for glucose repression. To assess whether the lacking CYR1 activation in CEN.PK could be the reason for the different responses to an HXK2 deletion, we also analyzed a CEN.PK strain with repaired CYR1, called JT4. In all experiments, the strains were grown aerobically in batch mode on glucose minimal medium and samples were taken at high residual glucose concentrations.
Physiological comparison
First, we determined the strains' physiology. Here, CEN.PK and JT4 are absolutely identical in terms of rates and yields (Tab. 2). This was also expected as the point mutation in CYR1 impairs the glucose-and acidification-induced cAMP increase in de-repressed cells, while glucose-repressed cells are usually thought to be not affected by this mutation (Vanhalewyn, et al., 1999) . The FY4 strain, in contrast, shows a lower growth rate than the two CEN.PK strains (Tab. 2). The yields, however, are very similar in all strains (Tab. 2). Further, all strains show a physiologically fully repressed metabolism with practically absent respiratory TCA cycle activity as determined by 13 C metabolic flux analysis (Fig. 1) . Overall, while the relative intracellular flux distribution is identical in all analyzed strains, the CEN.PK and the JT4 strain realize much higher metabolic rates than the FY4.
Significant differences occur when HXK2 is deleted: CEN.PK Δhxk2 shows a significantly reduced growth rate (0.22 h -1 ) and a derepressed metabolism reaching a biomass yield of biomass yield 0.43 gDW gglucose -1 which is comparable to fully respiring, glucose-limited cultures (van Dijken, et al., 2000) . This finding can be further substantiated by the pronounced effect on the respiratory TCA cycle activity, which increases from 0.024 (±0.003) to a high value of 0.735 (±0.020) in the HXK2 deletion mutant (cf. Fig. 1B ). This increase, however, is at least partially caused by the reduction of the growth rate provoked by the mutation. In CEN.PK, Blank and Sauer demonstrated that the respiratory TCA cycle activity inversely correlates with growth rate (Blank & Sauer, 2004) . Nevertheless, even after correcting for the growth rate related increase of the respiratory TCA cycle activity, a large portion of the observed increase in the HXK2 deletion mutant can still be attributed to the HXK2 deletion itself (Fig. 1B) .
In contrast, the FY4 Δhxk2 strain almost behaves like the corresponding parent strain with an almost identical growth rate (0.32 h -1 ), identical biomass yield (0.16 gDW gglucose -1 ) and significantly repressed respiratory TCA cycle activity (Fig. 1B) . A second independently generated HXK2 deletion in FY4 and in a FY4-related strain (YSBN6) confirmed that HXK2 deletion in the FY4 strain indeed has basically no effect on the physiology (cf. Supplementary Information).
In JT4, the HXK2 deletion results in a very small relief from glucose repression but not to the same extent as in the CEN.PK strain (biomass yield 0.19 gDW gglucose -1 in JT4 Δhxk2; cf. Fig. 1 for the respiratory TCA cycle activity). As in CEN.PK, the HXK2 deletion in JT4 also causes a drastic reduction of the growth rate (0.17 h -1 ). The comparison of CEN.PK Δhxk2 and JT4 Δhxk2, where the only difference is the repaired point mutation, demonstrates that the adenylate cyclase-mediated PKA pathway restores the physiological state of glucose repression in JT4 Δhxk2, but not the growth rate.
Overall, these findings indicate that in CEN.PK Hxk2 has an exclusive role for realizing the physiological state of glucose repression, while 'backup' systems for glucose repression must exist in JT4 and FY4. The question is whether the FY4 strain upon HXK2 deletion also draws on the PKA pathway to maintain glucose repression on physiological level. Alternatively, Hxk1 could also act as backup system or it is also possible that Hxk1 is active in FY4 already in the first place. Towards answering this question, we therefore performed an in-depth omics analysis of the wild-type parent strains. Using state of the art proteomics (Lange, et al., 2008) and metabolomics (Ewald, et al., 2009 ) techniques we determined the absolute amounts of 36 intracellular metabolites from central metabolism and the concentrations of 84 enzymes relative to an internal standard.
Omics comparison
On the metabolome level, the CEN.PK and the JT4 strains are very similar. However, we found significant differences between the CEN.PK/JT4 strains and the FY4 strain ( Fig. 2; Supplementary File 1) . In particular, the metabolites in the upper glycolysis and the pentose phosphate pathway exhibit higher concentrations in the CEN.PK (on average 2-fold). The metabolite data from TCA cycle intermediates indicate different substrate-to-product ratios in this part of the metabolic network (cf. Supplementary   Figure) . Particularly, several reactions (such as those catalyzed by enolase, isocitrate dehydrogenase, and succinate dehydrogenase), which are known to be influenced by glucose repression (Schuurmans, et al., 2008) , are further shifted from equilibrium (cf. Supplementary Figure) , indicating a lower catalytic capacity for these reactions (Kummel, et al., 2006) . Also, the proteome data revealed that the CEN.PK and JT4 strains are almost identical, while significant differences exist between the CEN.PK/JT4 strains and the FY4 ( Fig. 3; Supplementary File 2) . In general, the CEN.PK/JT4 strains have lower protein levels than the FY4 strain. In different parts of the central metabolic network, proteins were identified that are more than 8-fold less abundant in CEN.PK/JT4 compared to the FY4; e.g. the hexokinase 1 (Hxk1), the -ketoglutarate dehydrogenase (Kgd1), or the ,-trehalose-phosphate synthase (Tsl1). As a general trend, proteins with a lower abundance in CEN.PK/JT4 are proteins known to be glucose repressed (i.e. Hxk1, Glk1, Tdh1, Eno1, Pyk2, and Ald4) (Navarro-Avino, et al., 1999 , Rodriguez, et al., 2001 , Schuurmans, et al., 2008 . In fact, many of the less abundant proteins in CEN.PK have been shown to be transcriptionally upregulated upon deletion of HXK2 (Westergaard, et al., 2007) .
Differential transcription factor activity
In a statistical enrichment analysis of the proteome data we asked which transcription factors could have caused the differential protein expression patterns (cf. Material and Methods for details). This analysis revealed that the activities of the transcription factors Mig1, Nrg1, and Nrg2 are likely more active in CEN.PK (transcription factor p-value < 0.02). These repressors -known to be involved in glucose repression (Horak, et al., 2002) -are all downstream of Snf1, suggesting a lower Snf1 activity in CEN.PK.
The enrichment analysis further suggested the two transcription factors Msn2 and Msn4 to be less active in CEN.PK (p-values < 0.002). In addition to these activators' involvement in the general stress response, they are also known to mediate hyperosmotic shock resistance (Martinez-Pastor, et al., 1996) . In fact, we found that CEN.PK is much less resistant to hyperosmotic stress, as no CEN.PK cells survived a 40 min residence in a high osmolar glycerol solution, while the survival rate was 16% (±7%) for FY4. Stress resistance is known to be repressed by high PKA activity (Thevelein & de Winde, 1999) and as Msn2 was shown to be inversely correlated with cAMP levels and PKA activity (Gorner, et al., 1998) this suggests that CEN.PK has a higher PKA activity than FY4.
Differential cAMP concentrations
As a proxy for PKA activity, we determined the cAMP concentrations in the three wild-type strains and the corresponding HXK2 deletion strains. We found that the CEN.PK and JT4 strains have an approximately 2-fold higher cAMP level than the FY4 strain (Fig. 4) potentially causing the higher basal PKA activity in these strains that was inferred from the above analysis. While the HXK2 deletion strains of CEN.PK and FY4 exhibit similar cAMP levels as the corresponding parent strains, the cAMP level in the JT4
Δhxk2 strain was found to be significantly higher than in its parent strain -likely resulting in an increased PKA activity.
Discussion
We found that CEN.PK and JT4 are virtually identical on all levels under high glucose conditions. These two strains, however, are very different compared to the FY4 strain. We found much higher metabolic rates in the CEN.PK strains, while the relative intracellular flux distribution is identical in both strain families. The higher metabolic rates in the CEN.PK strain might be facilitated by an increased glucose uptake/glucose phosphorylation.
Despite the increased metabolic rates, the CEN.PK strains exhibit lower expression levels of many (known glucose repressed) enzymes. As identified by the statistical enrichment analysis, the differential protein expression pattern points to differential activity of the repressors Mig1, Nrg1, and Nrg2, which are targets of the kinase Snf1 being one of the key regulators for glucose repression (Santangelo, 2006) .
Such an increased glucose repression on the protein level invoked by the Hxk2/Snf1-pathway might be the result of the higher glycolytic fluxes in the CEN.PK strains, as glycolytic flux was found to correlate with the degree of glucose repression (Elbing, et al., 2004 , Otterstedt, et al., 2004 . As we found practically identical Hxk2 expression levels in both strains (CEN.PK/FY4 = 1.24 ± 0.21; cf. Supplementary
File 2) and also identical HXK2 amino acid sequences, the increased Hxk2 activity (i.e. the decreased Snf1 activity) in CEN.PK compared to FY4 is not due to different Hxk2 sequences or expression levels.
The decreased Snf1 activity in CEN.PK could also be caused by such increased PKA activity as PKA might have the potential to inactivate Snf1 activity (Haurie, et al., 2004 , Hedbacker, et al., 2004 , Slattery, et al., 2008 . Indeed, our experiments suggested a higher basal PKA activity in the CEN.PK strains. As the JT4 strain was found to be identical to the CEN.PK strain on all levels, the point mutation has obviously no effect in the wild-type CEN.PK. Hence, this mutation cannot be the reason for the observed differences in the CEN.PK and FY4 proteomes and metabolomes, which are likely rather a result of the differential Snf1 and PKA activity.
The different physiological responses upon the HXK2 deletion in the CEN.PK and JT4 strains indicate that an intact CYR1 is able to partly maintain glucose repression on the physiological level in a HXK2 deletion background. Indeed, the JT4 Δhxk2 strain has likely an increased PKA activity compared to JT4 as indicated by a significantly higher cAMP concentration in JT4 Δhxk2. In fact, a role for cAMP/PKA in catabolite repression was suggested earlier (Eraso & Gancedo, 1984 , Thompson-Jaeger, et al., 1991 .
Finally, we are still left with the question why CEN.PK and FY4 respond so differently on the physiological level to a HXK2 deletion. The polymorphism in the CYR1 can be excluded for two reasons: (i) repairing the CYR1 defect in CEN.PK Δhxk2 restores the physiological repression state but not the drop in the growth rate, while in FY4 Δhxk2 growth rate is also unaltered; (ii) cAMP levels in FY4 and FY4 Δhxk2 are identical indicating unaltered PKA activity in these two strains. (In contrast, we found increased cAMP levels in JT4 Δhxk2 compared to JT4 pointing to an increased PKA activity in the HXK2 deletion strain).
Thus, we hypothesize that in FY4 Hxk1 might be used a backup to (i) maintain a high glycolytic flux and to
(ii) sustain a Hxk(1/2)/Snf1 dependent glucose repression. This might not be possible in CEN.PK.
Conclusion
This paper reports a comparative multi-omic analysis of two important and commonly used yeast strains and a variant of one of them under high glucose conditions. We found significant differences in the metabolome, proteome and physiology of the two investigated yeast strain families and in the way how these strains realize glucose repression on the physiological level. Further, we generated novel evidence on the overlap between the classical glucose repression pathway and the glucose activated cAMP/PKA signaling pathway. The identified strain differences highlight the effects of genetic backgrounds on major metabolic pathways like those involved in glucose signaling and regulation. Although this unbiased comparison does not comprehensively answer all open questions it represents a starting point for further analysis that will likely reveal additional mechanisms involved in the phenomena reported.
Nevertheless, the results of our comparative study with two commonly used yeast strain familiesperformed with identical analytical platforms and identical conditions -will presumably have the potential to resolve some conflicting findings that exist in the field or at least provide possible explanations for unexplainable or unexpected observations. (Winston, et al., 1995) FY4 Δhxk2 FY4 hxk2::kanMX4 C. Boone, pers. comm. PK strains indicate the increase in respiratory TCA cycle activity that is related to the growth rate reduction caused by the gene deletion (as determined from (Blank & Sauer, 2004) 
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